CLINICAL_TRIALS ClinicalTrials.gov record update

A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06743113
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:41.583424+00:00
Published At: 2026-01-07T00:00:00+00:00
Record Updated At: 2026-01-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sickle Cell Anaemia", "Sickle Cell Anemia Crisis", "Sickle Cell Anemia in Children", "Sickle Cell Anemia (HbSS, or HbS\u03b2-thalassemia0)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-01-07"
protocolSection.identificationModule.nctId: "NCT06743113"
protocolSection.identificationModule.officialTitle: "A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE\u00ae System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.